Caitong International Asset Management Co., LTD Igm Biosciences, Inc. Transaction History
Caitong International Asset Management Co., LTD
- $102 Billion
- Q4 2024
A detailed history of Caitong International Asset Management Co., LTD transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 169 shares of IGMS stock, worth $241. This represents 0.0% of its overall portfolio holdings.
Number of Shares
169
Previous 169
-0.0%
Holding current value
$241
Previous $1.03 Million
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding IGMS
# of Institutions
85Shares Held
19.8MCall Options Held
75KPut Options Held
35.9K-
Baker Bros. Advisors LP New York, NY4.09MShares$5.85 Million0.28% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.57MShares$5.1 Million0.0% of portfolio
-
Siren, L.L.C. New York, NY3.33MShares$4.76 Million0.9% of portfolio
-
Redmile Group, LLC San Francisco, CA2.95MShares$4.22 Million1.41% of portfolio
-
Goldman Sachs Group Inc New York, NY978KShares$1.4 Million0.0% of portfolio
About IGM Biosciences, Inc.
- Ticker IGMS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,969,000
- Market Cap $41.4M
- Description
- IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...